Mark H. Einstein

12.3k total citations · 4 hit papers
136 papers, 7.8k citations indexed

About

Mark H. Einstein is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, Mark H. Einstein has authored 136 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Epidemiology, 46 papers in Oncology and 40 papers in Surgery. Recurrent topics in Mark H. Einstein's work include Cervical Cancer and HPV Research (93 papers), Genital Health and Disease (23 papers) and Global Cancer Incidence and Screening (19 papers). Mark H. Einstein is often cited by papers focused on Cervical Cancer and HPV Research (93 papers), Genital Health and Disease (23 papers) and Global Cancer Incidence and Screening (19 papers). Mark H. Einstein collaborates with scholars based in United States, Canada and United Kingdom. Mark H. Einstein's co-authors include Nicolas Wentzensen, Warner K. Huh, Henry C Kitchener, Silvia Franceschi, Emma J. Crosbie, Mark Schiffman, Walter Kinney, Herschel W. Lawson, Diane Solomon and Hormuzd A. Katki and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Mark H. Einstein

134 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human papillomavirus and cervical cancer

2013 841 citations Mark H. Einstein et al. profile →
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors

2020 737 citations David Chelmow, Mark H. Einstein et al. Journal of Lower Genital Tract Disease profile →
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

2013 678 citations L. Stewart Massad, Mark H. Einstein et al. Obstetrics and Gynecology profile →
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

2013 518 citations L. Stewart Massad, Mark H. Einstein et al. Journal of Lower Genital Tract Disease profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark H. Einstein United States	40	5.7k	2.3k	2.0k	1.1k	1.1k	136	7.8k
Sílvia de Sanjosé Spain	34	4.5k 0.8×	1.4k 0.6×	2.6k 1.3×	786 0.7×	1.3k 1.2×	171	7.6k
Brenda B. Rush United States	32	4.3k 0.8×	2.0k 0.8×	962 0.5×	836 0.8×	1.0k 1.0×	44	5.7k
Marcel V. Jacobs Netherlands	11	6.3k 1.1×	2.7k 1.2×	1.7k 0.8×	837 0.8×	1.6k 1.5×	11	7.7k
Peter Hillemanns Germany	42	3.4k 0.6×	1.8k 0.8×	1.5k 0.8×	1.5k 1.4×	1.1k 1.0×	385	7.2k
Laia Bruni Spain	27	9.6k 1.7×	3.9k 1.7×	2.8k 1.4×	1.1k 1.1×	1.6k 1.5×	58	12.0k
Ana Cecilia Rodríguez United States	42	7.1k 1.2×	3.1k 1.3×	1.4k 0.7×	739 0.7×	1.4k 1.3×	109	8.3k
José Jerónimo United States	42	5.9k 1.0×	2.1k 0.9×	2.3k 1.2×	753 0.7×	877 0.8×	154	7.2k
Thomas Iftner Germany	47	6.7k 1.2×	2.5k 1.1×	2.1k 1.1×	524 0.5×	2.0k 1.9×	197	8.4k
Warner K. Huh United States	49	5.0k 0.9×	2.5k 1.1×	2.3k 1.2×	3.0k 2.8×	833 0.8×	285	9.2k
Karl Ulrich Petry Germany	30	3.3k 0.6×	1.6k 0.7×	1.1k 0.5×	574 0.5×	692 0.6×	101	4.3k

Countries citing papers authored by Mark H. Einstein

Since Specialization

Citations

This map shows the geographic impact of Mark H. Einstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Einstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Einstein more than expected).

Fields of papers citing papers by Mark H. Einstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark H. Einstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Einstein. The network helps show where Mark H. Einstein may publish in the future.

Co-authorship network of co-authors of Mark H. Einstein

This figure shows the co-authorship network connecting the top 25 collaborators of Mark H. Einstein. A scholar is included among the top collaborators of Mark H. Einstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark H. Einstein. Mark H. Einstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Neibart, Shane S., Junzo Chino, Deanna Teoh, et al.. (2025). Health equity, disparities, and barriers to cervical cancer care in the U.S.: A consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS addressing the WHO cervical Cancer elimination campaign goals related to treatment. Gynecologic Oncology. 200. 186–192.

Arsdale, Anne Van, Joshua Gould, Koenraad Van Doorslaer, et al.. (2024). Structure and transcription of integrated HPV DNA in vulvar carcinomas. npj Genomic Medicine. 9(1). 35–35. 1 indexed citations

Rajdev, Lakshmi, Himanshu Joshi, Shelly Lensing, et al.. (2023). Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study. Cancer. 130(6). 985–994. 6 indexed citations

Merritt, Melissa A., Howard D. Strickler, Alan D. Hutson, et al.. (2021). Sex Hormones, Insulin, and Insulin-like Growth Factors in Recurrence of High-Stage Endometrial Cancer. Cancer Epidemiology Biomarkers & Prevention. 30(4). 719–726. 10 indexed citations

Xue, Zhiyun, Akiva P. Novetsky, Mark H. Einstein, et al.. (2020). A demonstration of automated visual evaluation of cervical images taken with a smartphone camera. International Journal of Cancer. 147(9). 2416–2423. 44 indexed citations

Chiao, Elizabeth Y., Shelly Lensing, Dorothy J. Wiley, et al.. (2020). Screening strategies for the detection of anal high-grade squamous intraepithelial lesions in women living with HIV. AIDS. 34(15). 2249–2258. 15 indexed citations

Hu, Liming, David Bell, Sameer Antani, et al.. (2019). An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening. Obstetrical & Gynecological Survey. 74(6). 343–344. 21 indexed citations

Wijetunga, N. Ari, Thomas J. Belbin, Robert D. Burk, et al.. (2016). Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia. Gynecologic Oncology. 142(3). 566–573. 30 indexed citations

Huh, Warner K., Kevin A. Ault, David Chelmow, et al.. (2015). Use of Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening. Obstetrics and Gynecology. 125(2). 330–337. 210 indexed citations

10.

Einstein, Mark H., Katherine Smith, Thomas E. Davis, et al.. (2014). Clinical Evaluation of the Cartridge-Based GeneXpert Human Papillomavirus Assay in Women Referred for Colposcopy. Journal of Clinical Microbiology. 52(6). 2089–2095. 72 indexed citations

11.

Massad, L. Stewart, Mark H. Einstein, Warner K. Huh, et al.. (2013). 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Obstetrics and Gynecology. 121(4). 829–846. 678 indexed citations breakdown →

12.

Massad, L. Stewart, Mark H. Einstein, Warner K. Huh, et al.. (2013). 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Journal of Lower Genital Tract Disease. 17(Supplement 1). S1–S27. 518 indexed citations breakdown →

13.

Reimers, Laura, et al.. (2011). Performance of Implementing Guideline-Driven Cervical Cancer Screening Measures in an Inner-City Hospital System. Journal of Lower Genital Tract Disease. 15(4). 296–302. 3 indexed citations

14.

Herzog, Thomas J., Warner K. Huh, & Mark H. Einstein. (2010). How does public policy impact cervical screening and vaccination strategies?. Gynecologic Oncology. 119(2). 175–180. 12 indexed citations

15.

Einstein, Mark H.. (2009). Comparative Immunogenicity of Two Prophylactic Human Papillomavirus Cervical Cancer Vaccines: Month 18 results. 1 indexed citations

16.

Doorslaer, Koenraad Van, Laura Reimers, Yevgeniy Y. Studentsov, Mark H. Einstein, & Robert D. Burk. (2009). Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia. Gynecologic Oncology. 116(2). 208–212. 24 indexed citations

17.

Einstein, Mark H., et al.. (2009). Genetic Variants in TAP Are Associated with High-Grade Cervical Neoplasia. Clinical Cancer Research. 15(3). 1019–1023. 47 indexed citations

18.

Huang, Gloria S., Mark H. Einstein, Dineo Khabele, & Gary L. Goldberg. (2003). Serum biomarkers for epithelial ovarian carcinoma. The Women s Oncology Review. 3(2). 117–122. 1 indexed citations

19.

Einstein, Mark H. & Gary L. Goldberg. (2002). Human Papillomavirus and Cervical Neoplasia. Cancer Investigation. 20(7-8). 1080–1085. 49 indexed citations

20.

Einstein, Mark H. & Robert D. Burk. (2001). Persistent human papillomavirus infection: Definitions and clinical implications. 12(5). 119–123. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact